# Effects of Heparin on Arteriovenous Fistula Patency

> **NCT02493504** · PHASE4 · COMPLETED · sponsor: **Fatemeh Hoseinzadegan** · enrollment: 150 (actual)

## Conditions studied

- Arteriovenous Fistula

## Interventions

- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT02493504
- **Lead sponsor:** Fatemeh Hoseinzadegan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-04
- **Final completion:** 2013-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2015-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02493504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02493504, "Effects of Heparin on Arteriovenous Fistula Patency". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02493504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*